Jazz Pharmaceuticals Debt to Equity Ratio 2007-2018 | JAZZ

Current and historical debt to equity ratio values for Jazz Pharmaceuticals (JAZZ) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Jazz Pharmaceuticals debt/equity for the three months ending September 30, 2018 was 0.52.
Jazz Pharmaceuticals Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $1.56B $3.03B 0.52
2018-06-30 $1.56B $2.87B 0.54
2018-03-31 $1.54B $2.79B 0.55
2017-12-31 $1.54B $2.71B 0.57
2017-09-30 $1.54B $2.47B 0.63
2017-06-30 $1.64B $2.20B 0.74
2017-03-31 $1.74B $1.98B 0.88
2016-12-31 $1.99B $1.88B 1.06
2016-09-30 $2.15B $1.72B 1.25
2016-06-30 $1.14B $1.69B 0.68
2016-03-31 $1.15B $1.61B 0.71
2015-12-31 $1.15B $1.60B 0.72
2015-09-30 $1.17B $1.56B 0.75
2015-06-30 $1.34B $1.45B 0.93
2015-03-31 $1.34B $1.31B 1.02
2014-12-31 $1.33B $1.37B 0.97
2014-09-30 $1.33B $1.34B 0.99
2014-06-30 $1.19B $1.28B 0.93
2014-03-31 $1.19B $1.27B 0.94
2013-12-31 $0.54B $1.30B 0.42
2013-09-30 $0.55B $1.24B 0.44
2013-06-30 $0.55B $1.18B 0.47
2013-03-31 $0.42B $1.16B 0.36
2012-12-31 $0.43B $1.12B 0.38
2012-09-30 $0.44B $0.89B 0.49
2012-06-30 $0.44B $0.83B 0.53
2012-03-31 $0.00B $0.78B 0.00
2011-12-31 $0.00B $0.19B 0.00
2011-09-30 $0.00B $0.14B 0.00
2011-06-30 $0.00B $0.10B 0.00
2011-03-31 $0.02B $0.06B 0.34
2010-12-31 $0.03B $0.03B 0.81
2010-09-30 $0.03B $-0.00B -35.62
2010-06-30 $0.03B $-0.02B -2.01
2010-03-31 $0.08B $-0.07B -1.16
2009-12-31 $0.09B $-0.07B -1.25
2009-09-30 $0.12B $-0.08B -1.40
2009-06-30 $0.12B $-0.09B -1.29
2009-03-31 $0.00B $-0.09B 0.00
2008-12-31 $0.00B $-0.09B 0.00
2008-09-30 $0.11B $-0.04B -2.98
2008-06-30 $0.11B $-0.04B -3.19
2008-03-31 $0.11B $0.01B 9.11
2007-12-31 $0.08B $0.06B 1.37
2007-09-30 $0.08B $0.11B 0.67
2007-06-30 $0.08B $0.13B 0.58
2007-03-31 $0.00B $0.00B 0.00
2006-12-31 $0.00B $0.00B 0.00
2006-09-30 $0.00B $0.00B 0.00
2006-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $8.637B $1.619B
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. They apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.375B 11.43
Zoetis (ZTS) United States $43.289B 29.64
Grifols (GRFS) Spain $14.701B 17.94
Tilray (TLRY) United States $9.945B 0.00
Neurocrine Biosciences (NBIX) United States $7.919B 1746.60
Ionis Pharmaceuticals (IONS) United States $7.377B 0.00
Nektar Therapeutics (NKTR) United States $6.579B 9.43
Impax Laboratories (AMRX) United States $5.589B 29.71
Catalent (CTLT) United States $5.483B 23.00
Sage Therapeutics (SAGE) United States $5.144B 0.00
United Therapeutics (UTHR) United States $5.079B 8.31
Loxo Oncology (LOXO) United States $4.598B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.943B 14.60
FibroGen (FGEN) United States $3.332B 0.00
USANA Health Sciences (USNA) United States $2.876B 24.48
Endo (ENDP) Ireland $2.795B 4.28
Xencor (XNCR) United States $2.152B 0.00
TESARO (TSRO) United States $2.027B 0.00
Aerie Pharmaceuticals (AERI) United States $1.980B 0.00
Endocyte (ECYT) United States $1.939B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.895B 256.00
Heron Therapeutics (HRTX) United States $1.876B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.855B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.843B 0.00
Zogenix (ZGNX) United States $1.690B 0.00
PTC Therapeutics (PTCT) United States $1.654B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.516B 18.55
Theravance Biopharma (TBPH) Cayman Islands $1.453B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.398B 0.00
Corcept Therapeutics (CORT) United States $1.396B 20.49
Portola Pharmaceuticals (PTLA) United States $1.285B 0.00
Esperion Therapeutics (ESPR) United States $1.264B 0.00
Tricida (TCDA) United States $1.234B 0.00
TherapeuticsMD (TXMD) United States $1.125B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.075B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.900B 0.00
ImmunoGen (IMGN) United States $0.826B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.720B 0.00
Radius Health (RDUS) United States $0.706B 0.00
Karyopharm Therapeutics (KPTI) United States $0.648B 0.00
Flexion Therapeutics (FLXN) United States $0.605B 0.00
Collegium Pharmaceutical (COLL) United States $0.565B 0.00
GlycoMimetics (GLYC) United States $0.498B 0.00
ChemoCentryx (CCXI) United States $0.477B 37.80
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.473B 0.00
Siga Technologies (SIGA) United States $0.453B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.445B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.425B 25.06
Dova Pharmaceuticals (DOVA) United States $0.423B 0.00
Odonate Therapeutics (ODT) United States $0.421B 0.00
Xeris Pharmaceuticals (XERS) United States $0.418B 0.00
Akebia Therapeutics (AKBA) United States $0.416B 0.00
Dermira (DERM) United States $0.409B 0.00
OptiNose (OPTN) United States $0.409B 0.00
Aquestive Therapeutics (AQST) United States $0.408B 0.00
ArQule (ARQL) United States $0.402B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.395B 0.00
Forty Seven (FTSV) United States $0.395B 0.00
Aclaris Therapeutics (ACRS) United States $0.359B 0.00
CASI Pharmaceuticals (CASI) United States $0.357B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.347B 0.00
Depomed (ASRT) United States $0.345B 12.83
Zafgen (ZFGN) United States $0.344B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.341B 0.00
KalVista Pharmaceuticals (KALV) United States $0.338B 0.00
Minerva Neurosciences (NERV) United States $0.324B 0.00
Aratana Therapeutics (PETX) United States $0.316B 0.00
Mast Therapeutics (SVRA) United States $0.315B 0.00
Translate Bio (TBIO) United States $0.309B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.304B 0.00
Concert Pharmaceuticals (CNCE) United States $0.303B 0.00
Tapimmune (MRKR) United States $0.301B 0.00
Affimed (AFMD) Germany $0.274B 0.00
Majesco Entertainment (PTE) United States $0.267B 0.00
IMV INC (IMV) Canada $0.248B 0.00
Lannett Co Inc (LCI) United States $0.241B 2.11
Aldeyra Therapeutics (ALDX) United States $0.235B 0.00
Tyme Technologies (TYME) United States $0.227B 0.00
Opexa Therapeutics (ACER) United States $0.221B 0.00
Ocular Therapeutix (OCUL) United States $0.215B 0.00
Galectin Therapeutics (GALT) United States $0.208B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.200B 0.00
MEI Pharma (MEIP) United States $0.194B 0.00
Calithera Biosciences (CALA) United States $0.189B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.189B 0.00
ElectroCore (ECOR) United States $0.182B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.181B 0.00
Neon Therapeutics (NTGN) United States $0.178B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.178B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.177B 0.00
Ardelyx (ARDX) United States $0.175B 0.00
Nature's Sunshine Products (NATR) United States $0.171B 0.00
Molecular Templates (MTEM) United States $0.169B 0.00
ContraFect (CFRX) United States $0.160B 0.00
Redhill Biopharma (RDHL) Israel $0.160B 0.00
MediWound (MDWD) Israel $0.157B 0.00
Jounce Therapeutics (JNCE) United States $0.150B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.148B 0.00
Melinta Therapeutics (MLNT) United States $0.146B 0.00
Recro Pharma (REPH) United States $0.141B 0.00
DURECT (DRRX) United States $0.138B 0.00
Adherex Technologies (FENC) United States $0.132B 0.00
ProNAi Therapeutics (SRRA) Canada $0.123B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.118B 0.00
Cardiome Pharma (CORV) Canada $0.115B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.114B 0.00
Champions Oncology (CSBR) United States $0.114B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.109B 0.00
Rafael Holdings (RFL) United States $0.108B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.099B 0.00
CTI BioPharma (CTIC) United States $0.096B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.093B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.089B 0.00
Achaogen (AKAO) United States $0.083B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.082B 0.00
Infinity Pharmaceuticals (INFI) United States $0.080B 0.00
Iterum Therapeutics (ITRM) Ireland $0.075B 0.00
Natural Alternatives (NAII) United States $0.074B 7.25
Otonomy (OTIC) United States $0.072B 0.00
Nivalis Therapeutics (ALPN) United States $0.070B 0.00
BioLineRx (BLRX) Israel $0.068B 0.00
KemPharm (KMPH) United States $0.068B 0.00
Immune Design (IMDZ) United States $0.065B 0.00
Forward Pharma (FWP) Denmark $0.062B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.061B 0.00
Novan (NOVN) United States $0.061B 0.00
Avenue Therapeutics (ATXI) United States $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 35.79
Neos Therapeutics (NEOS) United States $0.056B 0.00
Genocea Biosciences (GNCA) United States $0.050B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.049B 0.00
Capnia (SLNO) United States $0.047B 0.00
Heat Biologics (HTBX) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.040B 0.00
Trillium Therapeutics (TRIL) Canada $0.040B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.038B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.036B 0.00
ProPhase Labs (PRPH) United States $0.034B 3.87
Lipocine (LPCN) United States $0.030B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
IsoRay (ISR) United States $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
Xenetic Biosciences (XBIO) United States $0.026B 0.00
Onconova Therapeutics (ONTX) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
HANCOCK JAFFE (HJLI) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
NanoViricides (NNVC) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
Aviragen Therapeutics (VXRT) United States $0.020B 0.00
ESSA Pharma (EPIX) Canada $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Pain Therapeutics (PTIE) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 6.35
Shineco (TYHT) China $0.016B 1.61
Aradigm (ARDM) United States $0.015B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
Skyline Medical (AIPT) United States $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.010B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.009B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
PharmAthene (ALT) United States $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00